BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220725T120000
DTEND;TZID=America/New_York:20220725T130000
DTSTAMP:20260404T070133
CREATED:20220722T191732Z
LAST-MODIFIED:20220722T191732Z
UID:16862-1658750400-1658754000@www.masslifesciences.com
SUMMARY:Women Leadership in Biotech Summer Webinar Series
DESCRIPTION:In this four-part webinar series\, women leaders will speak about their career journeys and offer advice around the challenges and opportunities in navigating a biotech career. This free webinar series is designed primarily for women leaders at all levels\, but all are welcome. \nThe 2022  topics include: \n\nAddressing Imposter Syndrome in Biotech Leadership and How to Mitigate it\nThe Founder’s Journey: A Guide to Starting a Biotech\n\nJuly 25\, 2022  | 12:00 – 1:00 pm ET\nTwo extraordinary biotech founders Dr Pamela Contag and Dr Jo Viney\, together with moderator Dr Anna Frostegård\, share their journeys building biotech companies\, from initial inception\, investment\, development through to IPO. They will discuss key aspects of building a biotech\, challenges\, and what they wish they had known before embarking on their founders journey.\n\n\nNow that You Have a Seat on the Board\, What to Expect and How to Influence\n\nAugust 3\, 2022  | 12:00 – 1:00 pm ET\nThe board of directors play an essential role in assessing the overall direction and strategy of a business. In this webinar we address what to expect and how to influence as a board member. More specifically:  \n\nHow to break in once you’re on the board?\nHow you operate once you’re on the board\nKey pieces of advice\nHow do you ensure that you pave the way for future women on the board\nAddressing DEI\n\n\n\n\nHow to be Proactive as a Networker\n\nAugust 17\, 2022  | 12:00 – 1:00 pm ET\nWe all know that networking is essential in building a community\, ideas and actions. Networking can at times require a strategic and creative approach. It can also require planning and most certainly stepping outside one’s comfort zone. In this webinar\, our group of experienced biotech executives share best practices on how to be a more effective networker and how to maximize networking opportunities. In addition\, we also address: \n\nHow to evaluate women networking groups\nA look at traditional male networking\nHow to seek out people who can amplify your opportunity to build your personal brand and network\nCase examples
URL:https://www.masslifesciences.com/event/women-leadership-in-biotech-summer-webinar-series/2022-07-25/
LOCATION:Online\, online
ORGANIZER;CN="Conference Forum":MAILTO:service@tcfllc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220727T160000
DTEND;TZID=America/New_York:20220727T190000
DTSTAMP:20260404T070133
CREATED:20220721T144028Z
LAST-MODIFIED:20220721T144028Z
UID:16839-1658937600-1658948400@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-10/
LOCATION:MA
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220825T100000
DTEND;TZID=America/New_York:20220825T120000
DTSTAMP:20260404T070133
CREATED:20220822T210221Z
LAST-MODIFIED:20220822T210221Z
UID:17059-1661421600-1661428800@www.masslifesciences.com
SUMMARY:Engineering strategies for improving adoptive T cell therapy against cancer
DESCRIPTION:The adoptive cell transfer (ACT) of tumor-specific T cells has emerged as a potent treatment against some advanced cancers. For example\, ACT of ex vivo expanded tumor-infiltrating lymphocytes (TILs) has achieved durable and complete responses in about 20% of melanoma patients receiving a single transfusion. In addition\, TCR-redirected T cells targeting the cancer testis antigen NY-ESO-1157-165 have shown important clinical promise against melanoma\, myeloma\, and synovial sarcoma. Furthermore\, ACT with peripheral blood T cells gene-modified to express chimeric antigen receptor (CAR) T cells targeting the B-cell lineage antigen CD19 has led to complete remission for up to 90% of some advanced\, treatment-refractory hematological cancer patients. \nHowever\, unprecedented responses to CAR therapy have not been achieved against epithelial-derived solid tumors\, the most common category of cancers. Indeed\, solid tumors present a variety of barriers to CAR therapy\, including that there is a lack of tumor antigens not also found on healthy tissues\, thus running the risk of on-target but off-tumor toxicity. Hence\, both TCR- and CAR T cells face various immunosuppressive barriers in the solid tumor microenvironment (TME)\, which can be detrimental to their persistence and function. \nCreative Biolabs has invited Dr. Melita Irving to join us in this webinar section and discuss the latest findings of her research team on an innovative CAR design\, hoping to provide insights into the engineering strategies for improving the efficacy and safety of CAR and TCR cell therapies against cancer. \nDuring this webinar\, the following topics will be discussed: \nThe use of syngeneic tumor models to evaluate the ability of co-engineered murine CAR T cells to reprogram the TME and boost T cell function\nThe use of low doses of irradiation to inflame cold tumors and render them responsive to rational combinatorial immunotherapy\nThe novel STOP-CAR integrates efficacy and safety directly into CAR design
URL:https://www.masslifesciences.com/event/engineering-strategies-for-improving-adoptive-t-cell-therapy-against-cancer/
LOCATION:Virtual
ORGANIZER;CN="Creative Biolabs":MAILTO:marketing@creative-biolabs.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220829T090000
DTEND;TZID=America/New_York:20220830T220000
DTSTAMP:20260404T070133
CREATED:20220804T125625Z
LAST-MODIFIED:20220804T125625Z
UID:16927-1661763600-1661896800@www.masslifesciences.com
SUMMARY:Nucleate Summit 2022
DESCRIPTION:The Nucleate Summit will be hosted in Boston\, Massachusetts on August 29-30. \nThe two-day celebration will unify Nucleate’s worldwide community in person for the first time\, connecting hundreds of volunteers\, founders\, and investors. \nThe Leadership Summit (Day 1) includes shared experiences that will strengthen bonds among Nucleate leadership\, alumni\, special guests\, and sponsors. It will also invite participants to explore the city of Boston and its advanced biotech ecosystem. Here\, the action will be off-stage: attendees will form deep connections with biotech leaders and Nucleate’s partners. \nThe Community Summit (Day 2) includes premier networking opportunities\, inspirational speakers\, and the Activator Pitch Showcase\, features recent winners from the 9 Nucleate regions. Many other teams from the Activator 2022 cohort will also attend; they are building on $9 million in funding raised in just the past few weeks.
URL:https://www.masslifesciences.com/event/nucleate-summit-2022/
LOCATION:Royale\, 279 Tremont St\, Boston\, 02116\, United States
ORGANIZER;CN="Nucleate":MAILTO:contact@nucleate.xyz
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220831T160000
DTEND;TZID=America/New_York:20220831T190000
DTSTAMP:20260404T070133
CREATED:20220816T174559Z
LAST-MODIFIED:20220816T174559Z
UID:17043-1661961600-1661972400@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-11/
LOCATION:Virtual
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T131347Z
LAST-MODIFIED:20220711T131347Z
UID:16792-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Pharmacology – Essentials
DESCRIPTION:HMX Pro Pharmacology – Essentials covers the basic concepts required to understand the field of pharmacology today\, with an emphasis on the principles that describe what the body does to a drug and in turn what a drug does to the body.
URL:https://www.masslifesciences.com/event/pharmacology-essentials/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T131427Z
LAST-MODIFIED:20220711T131427Z
UID:16791-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Drug Discovery and Development
DESCRIPTION:With all the advances in science and with closer collaboration between different scientific disciplines\, a multifaceted approach is now being applied to drug discovery and development. Therefore\, learning about the process of drug discovery and development has important implications for anyone working in health care and related sectors. \nThis advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about how drugs are developed and about the advances happening in this field that are ultimately helping to improve the treatment and prevention of disease.
URL:https://www.masslifesciences.com/event/drug-discovery-and-development/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T131503Z
LAST-MODIFIED:20220711T131503Z
UID:16790-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Drug Delivery
DESCRIPTION:The range of systems and approaches that can be used to deliver therapeutics is growing and advancing at an incredible rate\, so learning about the advances in drug delivery has important implications for anyone working in health care and related sectors. \nThis online course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge drug delivery systems and approaches that can be used in the treatment and prevention of disease.
URL:https://www.masslifesciences.com/event/drug-delivery/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T131559Z
LAST-MODIFIED:20220711T131559Z
UID:16789-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Vaccines and Viral Immunology
DESCRIPTION:Viral infections are responsible for many human diseases\, from common diseases like the flu to emerging infections such as Zika virus and SARS-CoV-2. \nUnderstanding how the immune system works to prevent and remove viral infections is essential for anyone working to develop or distribute vaccines that can protect against these diseases. \nThis advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge developments in the creation of vaccines to protect against viral infections.
URL:https://www.masslifesciences.com/event/vaccines-and-viral-immunology/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T131632Z
LAST-MODIFIED:20220711T131632Z
UID:16788-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Novel Therapies for Chronic Inflammation\, Autoimmunity\, and Allergy
DESCRIPTION:Advances in our knowledge of the immune system are uncovering connections between inflammation and many different diseases. \nUnderstanding how the immune system is activated and regulated is essential for anyone working to develop treatments for autoimmunity\, chronic inflammation\, and allergy\, or to apply these treatments in the clinic. \nThis online course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge therapies to treat chronic inflammation and related diseases.
URL:https://www.masslifesciences.com/event/novel-therapies-for-chronic-inflammation-autoimmunity-and-allergy/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T131700Z
LAST-MODIFIED:20220711T131700Z
UID:16786-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Genetics – Essentials
DESCRIPTION:The way we diagnose and treat diseases is changing\, with new technologies enabled by a deeper understanding of the human genome and its relationship to health and disease. This shift has broad implications for those who work in health care and related areas. \nHMX Pro Genetics – Essentials covers the basic concepts required to understand the field of genetics today\, with an emphasis on explaining how variation in DNA sequence occurs\, is inherited\, and can lead to disease.
URL:https://www.masslifesciences.com/event/genetics-essentials/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T131743Z
LAST-MODIFIED:20220711T131743Z
UID:16787-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Immuno-oncology
DESCRIPTION:Advances in our knowledge of the immune system are changing the ways in which we treat various types of cancer. \nUnderstanding how immune cells recognize and kill cancer cells\, and what we can do to enhance their ability to fight cancer\, is important for anyone working to develop new cancer treatments or apply them in the clinic. \nThis advanced course offers a unique way for professionals to learn about cutting-edge cancer immunotherapies from leading Harvard Medical School faculty.
URL:https://www.masslifesciences.com/event/immuno-oncology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T132127Z
LAST-MODIFIED:20220711T132127Z
UID:16784-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Genetic Testing and Sequencing Technologies
DESCRIPTION:The field of genetic testing is expanding and evolving at an incredible rate\, thanks to our growing knowledge of genetic conditions\, dropping costs\, and higher demand. \nThis rapid expansion has dramatically changed how we diagnose and screen for genetic conditions\, who we test\, and how informative the results are. Learning about the recent advances in genetic testing and sequencing technologies has important implications for anyone working in health care and related sectors. \nThis course offers a unique way for professionals to learn about genetic testing and its applications from leading Harvard Medical School faculty.
URL:https://www.masslifesciences.com/event/genetic-testing-and-sequencing-technologies/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T132158Z
LAST-MODIFIED:20220711T132158Z
UID:16783-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Cancer Genomics and Precision Oncology
DESCRIPTION:Growing knowledge of human genetics is changing the way physicians and researchers approach diagnosis of cancer risk as well as treatment of various types of cancer. \nAnyone whose work intersects with cancer needs to understand the vital role that genetic information has begun to play in the field of oncology. \nThis advanced course offers a unique way for professionals to learn about key cancer genetics concepts and cutting-edge clinical applications from leading Harvard Medical School faculty.
URL:https://www.masslifesciences.com/event/cancer-genomics-and-precision-oncology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T132227Z
LAST-MODIFIED:20220711T132227Z
UID:16782-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Pharmacology
DESCRIPTION:Understanding how drugs act in the body is vital for effectively treating patients. \nIn HMX Fundamentals Pharmacology\, you’ll learn about the principles governing what the body does to a drug and in turn what a drug does to the body. Along the way you will see how this knowledge comes into play in real-world scenarios and clinical settings.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-pharmacology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T132305Z
LAST-MODIFIED:20220711T132305Z
UID:16780-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Genetics
DESCRIPTION:The way we diagnose and treat diseases is changing\, with new technologies enabled by a deeper understanding of the human genome and its relationship to health and disease. \nIn HMX Fundamentals Genetics\, you’ll get an overview of key concepts behind the evolving fields of human genetics\, genomics\, and precision medicine.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-genetics/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T132332Z
LAST-MODIFIED:20220711T132332Z
UID:16779-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Immunology
DESCRIPTION:Microbial life forms are an ever-present\, extremely dangerous threat to our survival\, against which the immune system must constantly defend. \nIn HMX Fundamentals Immunology\, you’ll learn about the processes that enable our immune systems to respond to evolving threats and learn about new\, immunology-based disease treatments.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-immunology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T132404Z
LAST-MODIFIED:20220711T132404Z
UID:16778-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Physiology
DESCRIPTION:Understanding how the body works is vital for effectively treating patients. \nIn HMX Fundamentals Physiology\, you’ll learn essential principles underlying how the human body functions\, and see how this knowledge comes into play in real-world scenarios and in clinical settings from the intensive care unit to the cardiac catheterization lab.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-physiology/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220711T141804Z
LAST-MODIFIED:20220711T141804Z
UID:16781-1662422400-1668815999@www.masslifesciences.com
SUMMARY:HMX Fundamentals - Biochemistry
DESCRIPTION:Understanding biochemistry is an excellent foundation for learning all of biology\, but it can be difficult to make sense of the complexity of biochemical systems. \nIn HMX Fundamentals Biochemistry\, you’ll learn about the principles governing the interactions of individual molecules\, and how those same principles apply at the scale of cells and organisms. Along the way\, you’ll see how biochemistry intersects with human disease and clinical care.
URL:https://www.masslifesciences.com/event/hmx-fundamentals-biochemistry/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260404T070133
CREATED:20220712T131750Z
LAST-MODIFIED:20220712T131750Z
UID:16785-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Gene Therapy
DESCRIPTION:With all the advances in science and with closer collaboration between different scientific disciplines\, gene therapy has become a promising treatment option for some genetic conditions and is being heavily investigated for many others. Therefore\, learning about gene therapy and how it’s done has important implications for anyone working in health care and related sectors. \nThis advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about gene therapy and about the advances happening in this field that are ultimately helping to improve the treatment of certain genetic diseases.
URL:https://www.masslifesciences.com/event/gene-therapy/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220912
DTEND;VALUE=DATE:20220913
DTSTAMP:20260404T070133
CREATED:20220725T174748Z
LAST-MODIFIED:20220725T174748Z
UID:16871-1662940800-1663027199@www.masslifesciences.com
SUMMARY:9th Annual Mobile Tech in Clinical Trials
DESCRIPTION:This conference helps R&D operation executives support more patients remotely and to understand where these technologies will and won’t work to ensure full patient support while managing invaluable data collection. \nThe 9th annual event presents the largest number pharma and biotech participation to date who report on mobile and digital implementation strategies and demonstrate the impact of those initiatives.
URL:https://www.masslifesciences.com/event/9th-annual-mobile-tech-in-clinical-trials/
LOCATION:The Westin Copley Place Boston Hotel\, 10 Huntington Ave Boston Massachusetts 2116 United States of\, 10 Huntington Ave\, Boston\, MA\, 2116\, United States
ORGANIZER;CN="Conference Forum":MAILTO:service@tcfllc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220912
DTEND;VALUE=DATE:20220913
DTSTAMP:20260404T070133
CREATED:20220802T134640Z
LAST-MODIFIED:20220802T134640Z
UID:16916-1662940800-1663027199@www.masslifesciences.com
SUMMARY:Clinical Research as a Care Option
DESCRIPTION:Embedding clinical research in the care setting can lead to higher rates of clinical trial participation inside of a health system\, better health outcomes\, lower cost of care and more satisfied patients. CRAACO® is a unique opportunity for pharma\, healthcare and patients to come together and address how we can build a more integrated research ready platform to improve patient access to clinical trials.
URL:https://www.masslifesciences.com/event/clinical-research-as-a-care-option/
LOCATION:The Westin Copley Place Boston Hotel\, 10 Huntington Ave Boston Massachusetts 2116 United States of\, 10 Huntington Ave\, Boston\, MA\, 2116\, United States
ORGANIZER;CN="Conference Forum":MAILTO:service@tcfllc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220912T080000
DTEND;TZID=America/New_York:20220923T170000
DTSTAMP:20260404T070133
CREATED:20220712T132028Z
LAST-MODIFIED:20220712T132028Z
UID:16772-1662969600-1663952400@www.masslifesciences.com
SUMMARY:Designing and Implementing AI Solutions for Health Care
DESCRIPTION:Applications of artificial intelligence in health care are expanding rapidly. Despite its great long-term potential\, risks and challenges remain for both AI developers and their partners in health care\, the life sciences industry and digital health. \nThis program will allow leaders across the ecosystem to gain insights into what it takes to successfully utilize AI in the unique cultural\, economic and regulatory context of health care. Interactive sessions will address technical concepts as well as real-world implementation\, with examples drawn from health care delivery/operations and drug development. \nThe curriculum will feature a combination of live virtual class sessions\, small group application exercises\, pre-work and vigorous discussions. Upon completion of the program\, participants will be able to immediately apply insights gained to the fast-moving and complex health care sector. A certificate of completion will be provided.
URL:https://www.masslifesciences.com/event/designing-and-implementing-ai-solutions-for-health-care-4/
LOCATION:MA
ORGANIZER;CN="Harvard Medical School External Education":MAILTO:sqil@hms.harvard.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220912T103000
DTEND;TZID=America/New_York:20220912T113000
DTSTAMP:20260404T070133
CREATED:20220831T135231Z
LAST-MODIFIED:20220831T135231Z
UID:17213-1662978600-1662982200@www.masslifesciences.com
SUMMARY:Angel Investor Tax Credit Program - Virtual Info Session
DESCRIPTION:To learn more about our Angel Investor Tax Credit program\, register for our virtual info session that is being held on Sept. 12 at 10:30 a.m. Both early-stage life science company and investor applicants should attend this virtual session to learn more about this program and talk directly with MLSC staff. \nDeadline to apply is Jan. 5\, 2023.
URL:https://www.masslifesciences.com/event/angel-investor-tax-credit-program-virtual-info-session/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220913
DTEND;VALUE=DATE:20220915
DTSTAMP:20260404T070133
CREATED:20220725T172319Z
LAST-MODIFIED:20220725T172319Z
UID:16868-1663027200-1663199999@www.masslifesciences.com
SUMMARY:DPHARM: Disruptive Innovations Conference
DESCRIPTION:DPHARM® offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations to modernize clinical trials. \nDPHARM faculty challenge the clinical operations community to rethink how clinical research gets done to drive greater inclusivity and value for patients.
URL:https://www.masslifesciences.com/event/dpharm-disruptive-innovations-conference/
LOCATION:The Westin Copley Place Boston Hotel\, 10 Huntington Ave Boston Massachusetts 2116 United States of\, 10 Huntington Ave\, Boston\, MA\, 2116\, United States
ORGANIZER;CN="Conference Forum":MAILTO:service@tcfllc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220915T120000
DTEND;TZID=America/New_York:20220915T130000
DTSTAMP:20260404T070133
CREATED:20220916T143601Z
LAST-MODIFIED:20220916T143601Z
UID:17456-1663243200-1663246800@www.masslifesciences.com
SUMMARY:Emma Tello Lunch and Learn
DESCRIPTION:Emma Tello will be discussing IP protection strategies at the UMass Lowell Innovation Hub – Don’t miss out! \nAbout this event\nEmma Tello will be discussing IP protection strategies\, covering topics including patent vs trade secret\, branding\, and additional steps for biomed/tech companies! Come by the UMass Lowell Innovation Hub on September 15th for great information and FREE Lunch! \nEMMA TELLO \nEmma Tello\, Esq. is a licensed attorney in the state of Massachusetts and practices in the field of intellectual property and business law. She received her J.D. with a concentration in Intellectual Property at Northeastern University School of Law. She studied Environmental Science and received her B.S. from UMass Lowell. \nMs. Tello has two years of experience working with patents\, trademarks\, general intellectual property needs and business formation and regulation. Her previous clients include RevBio\, UMass Lowell’s Office of Technology Commercialization\, M2D2\, and numerous startup companies.
URL:https://www.masslifesciences.com/event/emma-tello-lunch-and-learn/
LOCATION:110 Canal St\, 110 Canal St\, Lowell\, MA\, 01854\, United States
ORGANIZER;CN="UMass Lowell Innovation Hub":MAILTO:kaylaundra_washington@uml.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220915T160000
DTEND;TZID=America/New_York:20220915T170000
DTSTAMP:20260404T070133
CREATED:20220831T134554Z
LAST-MODIFIED:20220831T135305Z
UID:17209-1663257600-1663261200@www.masslifesciences.com
SUMMARY:Angel Investor Tax Credit Program - Info Session
DESCRIPTION:Please join the Massachusetts Life Sciences Center (MLSC) on September 15 from 4 – 5 p.m. at the Cambridge Innovation Center in Kendall Square to learn more about our Angel Investor Tax Credit program. Both early-stage life science company and investor applicants should attend this in person session to learn more about this program and talk directly with MLSC staff. \nDeadline to apply is Jan. 5\, 2023. \nFollowing the info session\, attendees can join Venture Café for their weekly Thursday Gathering where founders and funders can network and learn about MA State funding opportunities until 7:30PM – all are welcome to attend. The event is free and the pre-registration link is here.
URL:https://www.masslifesciences.com/event/angel-investor-tax-credit-program-info-session-2/
LOCATION:Cambridge Innovation Center\, 1 Broadway\, Cambridge\, Massachusetts\, 02142
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220916T113000
DTEND;TZID=America/New_York:20220916T123000
DTSTAMP:20260404T070133
CREATED:20220902T113831Z
LAST-MODIFIED:20220902T113831Z
UID:17217-1663327800-1663331400@www.masslifesciences.com
SUMMARY:Capital Programs and Women's Health Programs - Virtual Info Session
DESCRIPTION:To learn more about the funding opportunities for our capital and women’s health programs listed below\, register for one of three virtual informational sessions MLSC staff will be hosting. \nSeptember 16\, 2022 at 11:30 a.m. – Register now\nSeptember 26\, 2022 at 2 p.m. – Register now\nOctober 13\, 2022 at 10:30 a.m. – Register now \nPrograms discussed: \nBits to Bytes: grants for scientific projects that generate and analyze large datasets to answer pressing life science questions\, and to attract and train data scientists in the Commonwealth. \nNovel Therapeutics Delivery: capitalize and incentivize translational projects to address complex challenges in “therapeutic” delivery—from biomanufacturing\, to targeted delivery\, to biomaterials and more. \nResearch Infrastructure: grants for capital projects that catalyze the life sciences ecosystem in by accelerating life sciences research and development in the Commonwealth. \nFirst Look Awards: Supporting translational research at Massachusetts research institutions that furthers our understanding of sex and gender differences especially for diseases or conditions that affect women exclusively\, predominately\, or differentially. \nWomen’s Health Innovation Grants: Fostering the development of new technologies to deliver innovative therapies.
URL:https://www.masslifesciences.com/event/capital-programs-and-womens-health-programs-virtual-info-session-2/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220921T080000
DTEND;TZID=America/New_York:20220921T090000
DTSTAMP:20260404T070133
CREATED:20220916T143044Z
LAST-MODIFIED:20220916T143044Z
UID:17512-1663747200-1663750800@www.masslifesciences.com
SUMMARY:Uncovering Preparedness Solutions in the African Innovation Ecosystem
DESCRIPTION:Global preparedness requires tapping into the world’s vast innovation ecosystems to drive forward preparedness capabilities needed to unlock potential solutions for tomorrow’s known and unknown health threats. While all regions face distinct challenges\, they also hold unique strengths that can contribute to global preparedness. During this session\, dive deeper into the strengths of the Africa region and how capabilities from the continent could contribute to global challenges. \nJoin as local and global industry leaders discuss: \nAfrica’s regional strengths and priorities for developing deployable\, inclusive preparedness potential solutions\nUnique capabilities across the African continent\nWhat is needed to scale regional strengths and address innovation gaps in the Africa region and globally\nRegional investments and initiatives that are helping to support and expand Africa’s innovation ecosystem\nExamples of successes and opportunities to engage with the region to contribute to global impact \nThis virtual event is a product of a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA)\, part of the Office of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services.
URL:https://www.masslifesciences.com/event/uncovering-preparedness-solutions-in-the-african-innovation-ecosystem/
LOCATION:Virtual Event
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220921T120000
DTEND;TZID=America/New_York:20220921T130000
DTSTAMP:20260404T070133
CREATED:20220916T143422Z
LAST-MODIFIED:20220916T143422Z
UID:17461-1663761600-1663765200@www.masslifesciences.com
SUMMARY:Marketing Hacks For Start Ups - Lunch and Learn
DESCRIPTION:Designed for non-marketers: Proven strategies and tools to jump-start your marketing. \nAbout this event\nGetting your healthcare innovative product or service off the ground is Job #1 for your startup. But you also have to market it — first to investors\, then to customers. Time is tight\, so is your budget. (And oh — marketing may not be your expertise.) What are your options? \nJoin Brian Bolton and Kelsey Flannery of StitchDX for lunch at M2D2 on September 21. You’ll learn that marketing your healthtech startup isn’t such a heavy lift when you combine budget-friendly HubSpot martech with a few proven strategic hacks. \nBring your appetite for a bigger business AND share your growth challenges. Let’s see what solutions we can serve up. \n*Attendees who register by noon on Tuesday\, September 20th\, are guaranteed a free lunch.
URL:https://www.masslifesciences.com/event/marketing-hacks-for-start-ups-lunch-and-learn/
LOCATION:110 Canal St\, 110 Canal St\, Lowell\, MA\, 01854\, United States
END:VEVENT
END:VCALENDAR